Arthroscopic Rotator Cuff Repair With Multimodal Analgesia(MMA)
1 other identifier
interventional
54
1 country
1
Brief Summary
- The purpose of this study is to compare the efficacy of periarticular injections consisting of ropivacaine, morphine, epinephrine, cefotetan, and hyaluronic acid with the efficacy of periarticular injections consisting of the same amount of placebo(isotonic saline) during arthroscopic rotator cuff repair.
- Adding of multimodal analgesia(MMA) to conventional rotator cuff repair, it was expected that could reduce postoperative pain and narcotic consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 16, 2010
CompletedFirst Posted
Study publicly available on registry
September 17, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedMarch 12, 2013
March 1, 2013
6 months
September 16, 2010
March 11, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale(VAS) for Pain
postoperative 5 hours
Secondary Outcomes (1)
Postoperative narcotic consumption
every 6 hours after surgery
Study Arms (2)
MMA group
EXPERIMENTALControl group
PLACEBO COMPARATORInterventions
* Under general anesthesia, the patient was placed in the lazy lateral decubitus position on the operating table. * The surgical area was prepared and draped with Betadine. * Small stab incisions were made in the creation of 4 or 5 portals as needed. * A scope was explored via the arthroscopic portal into the GH joint \& subacromial space. * Repaired of rotator cuff tear was done with suture anchors. * Mixed MMA drugs(ropivacaine 300mg;40ml, morphine 10mg;1ml, cefotetan 1g; dilution to ropivacaine, epinephrine 0.3mg;0.3ml, total volume:41.3ml) and sodium hyaluronate 20mg;2ml were injected divisionally periarticular area; intra-articular(sodium hyaluronate 20ml;2ml + 10.3ml); posterior joint capsule(10ml); subacromial space and around suprascapular nerve(11ml); anterior capsule(10ml). * The skin was closed with Nylon or medical staples. * Sterile dressing was applied on surgical wound. * Peripheral intravenous PCA(Patient Controlled Analgesia) was connected.
* Under general anesthesia, the patient was placed in the lazy lateral decubitus position on the operating table. * The surgical area was prepared and draped with Betadine. * Small stab incisions were made in the creation of 4 or 5 portals as needed. * A scope was explored via the arthroscopic portal into the GH joint \& subacromial space. * Repaired of rotator cuff tear was done with suture anchors. * 43.3ml of saline was injected divisionally periarticular area; intra-articular(12.3ml); posterior joint capsule(10ml); subacromial space and around suprascapular nerve(11ml); anterior capsule(10ml). * The skin was closed with Nylon or medical staples. * Sterile dressing was applied on surgical wound. * Peripheral intravenous PCA(Patient Controlled Analgesia) was connected.
Eligibility Criteria
You may qualify if:
- rotator cuff tear
- arthroscopic surgery
You may not qualify if:
- age\<45 or \>85
- allergies to the drugs used in the study
- acute trauma history
- history of renal disease
- history of hepatic disease
- osteoarthritis or rheumatic arthritis
- systemic condition with chronic pain
- history of infection
- could not understand the questions
- rotator cuff tear treated by the open technique, by debridement only
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joint and Spine Center; SMG-SNU Boramae Medical Center
Seoul, 156-707, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chris H. Jo, M.D., Ph.D
Seoul Metropolitan Government Seoul National University Boramae Medical Center; Joint and Spine Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 16, 2010
First Posted
September 17, 2010
Study Start
September 1, 2010
Primary Completion
March 1, 2011
Last Updated
March 12, 2013
Record last verified: 2013-03